Europe Glucose Monitoring System (Cgms & Smbg) Market Forecast 2017-2025KEY FINDINGS
Europe CGMS market is anticipated to augment in the year 2025 to $1822.54 million, The SMBG Europe market is expected to grow with the CAGR 8.14%. The forecast period of the GMS market is from 2017 to 2025 and the base year deliberated for the market study is 2016. High acceleration in the prevalence of diabetes, rising health awareness in developing countries, changes in lifestyle, sedentary lifestyle, the rise in the need of efficient and hassle-free monitoring of blood and the launch of an artificial pancreas are the drivers proliferating the growth of the GMS market in Europe region.
It is anticipated that the insulin pumps will show a good CAGR by capturing a big market share. An effective growth rate for Sensors is also expected during the forecast period. The GMS market is segmented by component type and application. The CGMS market by applications includes hospitals, homes, diagnostics and clinics and the component product types include transmitters, receivers, and sensors. The Sensors are further segmented on the basis of holter type insulin pumps, retrospective sensors, noninvasive glucose sensors, real-time sensors and minimally invasive glucose sensors. The SMBG market by application is segmented into clinics, home settings, and hospitals. The component type market segments into the glucose meter, test strips, and others. The countries mentioned in the Europe GMS market are France, Germany, UK, and Rest of Europe.
Key players in the market of GMS are Dexcom Inc., Insulet Corporation, Abbott Laboratories, Ypsomed AG, Bayer AG Roche, Medtronic Inc., Novo Nordisk, Animas Corporation, and Glysens Inc.